Merck Brings Customers Closer to Gene Therapy Product Commercialization – TASS
|
Merck Brings Customers Closer to Gene Therapy Product Commercialization
TASS DARMSTADT, Germany, Oct. 19, 2017 /PRNewswire/. Merck, a leading science and technology company, today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has … |
